We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHLTW
13201
DELISTED
Future Health ESG Corp. Warrant
FHLTW
$9.02K ﹤0.01%
450,927
-199
-0% -$8
CRBU icon
13202
Caribou Biosciences
CRBU
$157M
$9.01K ﹤0.01%
2,121
-280,729
-99% -$1.26M
NUVB icon
13203
CALL
Nuvation Bio
NUVB
$2.18B
$9K ﹤0.01%
5,000
+4,900
+4,900% +$8.33K
NRSNW icon
13204
NeuroSense Therapeutics Warrant
NRSNW
$8.96K ﹤0.01%
37,934
+5,323
+16% +$1.68K
HAFC icon
13205
PUT
Hanmi Financial
HAFC
$962M
$8.96K ﹤0.01%
600
CELU icon
13206
Celularity
CELU
$20.1M
$8.94K ﹤0.01%
+1,678
New +$10.7K
DRTSW icon
13207
Alpha Tau Medical Warrant
DRTSW
$87.6M
$8.89K ﹤0.01%
+22,506
New +$6.87K
WHWK
13208
PUT
Whitehawk Therapeutics
WHWK
$254M
$8.89K ﹤0.01%
1,300
-1,300
-50% -$10.1K
NEON icon
13209
CALL
Neonode
NEON
$15.3M
$8.89K ﹤0.01%
1,100
-4,900
-82% -$36.6K
VRAY
13210
CALL
DELISTED
ViewRay, Inc.
VRAY
$8.88K ﹤0.01%
25,200
+3,700
+17% +$3.83K
ACCO icon
13211
PUT
Acco Brands
ACCO
$401M
$8.86K ﹤0.01%
1,700
-8,900
-84% -$44.8K
NNBR icon
13212
PUT
NN Inc
NNBR
$322M
$8.84K ﹤0.01%
3,700
-2,200
-37% -$3.33K
BBCP icon
13213
CALL
Concrete Pumping Holdings
BBCP
$484M
$8.83K ﹤0.01%
1,100
-6,800
-86% -$47.9K
FINX icon
13214
PUT
Global X FinTech ETF
FINX
$170M
$8.83K ﹤0.01%
400
-800
-67% -$16.7K
GLAD icon
13215
PUT
Gladstone Capital
GLAD
$446M
$8.78K ﹤0.01%
450
-4,700
-91% -$89.1K
VNRX icon
13216
VolitionRx Ltd
VNRX
$6.47M
$8.78K ﹤0.01%
316
-700
-69% -$23K
MAGN
13217
CALL
Magnera Corp
MAGN
$444M
$8.76K ﹤0.01%
223
+208
+1,387% +$9.43K
INO icon
13218
PUT
Inovio Pharmaceuticals
INO
$113M
$8.75K ﹤0.01%
1,633
-8,284
-84% -$66.8K
ABTS icon
13219
Abits Group
ABTS
$3.91M
$8.74K ﹤0.01%
647
-2,060
-76% -$28.8K
FZT.WS
13220
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$8.72K ﹤0.01%
+12,481
New +$6.89K
FLNT
13221
CALL
Fluent
FLNT
$129M
$8.71K ﹤0.01%
2,317
+250
+12% +$1.05K
IMNM icon
13222
Immunome
IMNM
$3.09B
$8.69K ﹤0.01%
1,099
-1,841
-63% -$10.1K
BRLT icon
13223
Brilliant Earth
BRLT
$22.5M
$8.68K ﹤0.01%
2,238
+181
+9% +$687
WHG icon
13224
CALL
Westwood Holdings Group
WHG
$186M
$8.68K ﹤0.01%
700
-500
-42% -$6.13K
TG icon
13225
PUT
Tredegar Corp
TG
$276M
$8.67K ﹤0.01%
1,300
+100
+8% +$793

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.